Next, we explored possible risk factors for lymphopenia in the pretreatment patient characteristics, including age, sex, performance status, BMI, clinical TNM staging, clinical stage, tumor location, diabetes mellitus, hemoglobin, albumin, lymphocytes, and WBC. This evidence concerns the gene ALB and lymphopenia.